Vimarsana
Biggest News Aggregation in the World

Page 4 - Evaluate Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluate Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluate Pharma Today - Breaking & Trending Today

12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds - Vimarsana News

12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds

In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.

2 Risky Stocks With Massive Potential | The Motley Fool - Vimarsana News

2 Risky Stocks With Massive Potential | The Motley Fool

Neither is doing well this year.

Source: fool.com
Cathie Wood Is Buying CRISPR Therapeutics Ahead of This Big Event. Should You? - Vimarsana News

Cathie Wood Is Buying CRISPR Therapeutics Ahead of This Big Event. Should You?

Wood has outperformed the market so far this year.

Source: fool.com
3 Reasons to Buy Merck Stock | The Motley Fool - Vimarsana News

3 Reasons to Buy Merck Stock | The Motley Fool

This list is by no means exhaustive.

Source: fool.com
SK Pharmteco takes over US contract drugmaker CBM - Vimarsana News

SK Pharmteco takes over US contract drugmaker CBM

SK Pharmteco, a global contract development and manufacturing organization under Korean conglomerate SK Group, said Wednesday that it has acquired the Center for Breakthrough Medicines, a US cell and gene therapy firm. The Korean firm exercised its right to acquire a controlling stake in CBM to obtain the management right of the Philadelphia-based cell and gene therapy CDMO, offering pre-clinical to commercial phase ...